![]() |
Mallinckrodt to launch mid-stage study of Acthar Gel in ALS in H1 2017
Mallinckrodt to launch mid-stage study of Acthar Gel in ALS in H1 2017
Mallinckrodt to launch mid-stage study of Acthar Gel in ALS in H1 2 17 - Mallinckrodt PLC (NYSE:MNK) | Seeking Alpha |
All times are GMT -5. The time now is 05:00 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.